The DESolve Scaffold System is one of Elixir Medical’s latest advancements - a state-of-the-art novolimus-eluting bioresorbable coronary scaffold system that represents the next generation in scaffold technology. Unlike conventional metal stents, DESolve degrades in about 1 year, leaving behind a thin neointimal lining and well-maintained lumen - similar to a de novo vessel. Potential additional benefits include a functional endothelium enabling vasomotion and uniform flow dynamics in the vessel.